BCRX
Biocryst Pharmaceuticals
$7.88
+$0.23 (+3.01%)Oct 26, 2026
Key metrics
The numbers that frame BCRX today
- Market cap
- $2.01B
- EV / FCF
- 7.2
- Gross margin
- 97.8%
- EV / Sales
- 2.9
- ROIC
- -34.5%
- Div yield
- 0%
- 52wk Low
- $6.23
- 52wk High
- $11.22
Growth
Revenue and earnings trend for BCRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BCRX
Is Biocryst Pharmaceuticals a good buy?
Yes. Biocryst Pharmaceuticals has excellent quality and strong momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Biocryst Pharmaceuticals is selling at a fair price.
What is the market capitalization of BCRX?
Biocryst Pharmaceuticals's market capitalization is $2.01B.
What is the 52-week high for BCRX stock?
The 52-week high for Biocryst Pharmaceuticals is $11.22. The current close of $7.88 is 29.8% below that high.
What is the 52-week low for BCRX stock?
The 52-week low for Biocryst Pharmaceuticals is $6.23. The current close of $7.88 is 26.5% above that low.
Does BCRX stock pay dividends?
Biocryst Pharmaceuticals does not currently show a dividend per share in the company data.